{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:04:05Z","timestamp":1792836245175,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007900","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000}}],"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The study of response to cancer treatments has benefited greatly from the contribution of different omics data but their interpretation is sometimes difficult. Some mathematical models based on prior biological knowledge of signaling pathways facilitate this interpretation but often require fitting of their parameters using perturbation data. We propose a more qualitative mechanistic approach, based on logical formalism and on the sole mapping and interpretation of omics data, and able to recover differences in sensitivity to gene inhibition without model training. This approach is showcased by the study of BRAF inhibition in patients with melanomas and colorectal cancers who experience significant differences in sensitivity despite similar omics profiles.<\/jats:p>\n                  <jats:p>We first gather information from literature and build a logical model summarizing the regulatory network of the mitogen-activated protein kinase (MAPK) pathway surrounding BRAF, with factors involved in the BRAF inhibition resistance mechanisms. The relevance of this model is verified by automatically assessing that it qualitatively reproduces response or resistance behaviors identified in the literature. Data from over 100 melanoma and colorectal cancer cell lines are then used to validate the model\u2019s ability to explain differences in sensitivity. This generic model is transformed into personalized cell line-specific logical models by integrating the omics information of the cell lines as constraints of the model. The use of mutations alone allows personalized models to correlate significantly with experimental sensitivities to BRAF inhibition, both from drug and CRISPR targeting, and even better with the joint use of mutations and RNA, supporting multi-omics mechanistic models. A comparison of these untrained models with learning approaches highlights similarities in interpretation and complementarity depending on the size of the datasets.<\/jats:p>\n                  <jats:p>This parsimonious pipeline, which can easily be extended to other biological questions, makes it possible to explore the mechanistic causes of the response to treatment, on an individualized basis.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1007900","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T14:48:43Z","timestamp":1611845323000},"page":"e1007900","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Personalized logical models to investigate cancer response to BRAF treatments in melanomas and colorectal cancers"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1949-9801","authenticated-orcid":true,"given":"Jonas","family":"B\u00e9al","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pantolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-291X","authenticated-orcid":true,"given":"Vincent","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-2002","authenticated-orcid":true,"given":"Emmanuel","family":"Barillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7835-1148","authenticated-orcid":true,"given":"Laurence","family":"Calzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"issue":"8","key":"pcbi.1007900.ref001","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"B Vogelstein","year":"2004","journal-title":"Nature medicine"},{"issue":"2","key":"pcbi.1007900.ref002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"KA Hoadley","year":"2018","journal-title":"Cell"},{"issue":"12","key":"pcbi.1007900.ref003","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"JC Costello","year":"2014","journal-title":"Nature biotechnology"},{"issue":"12","key":"pcbi.1007900.ref004","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-17-0078","article-title":"Drug Resistance mechanisms in colorectal cancer dissected with cell type\u2013specific dynamic logic models","volume":"77","author":"F Eduati","year":"2017","journal-title":"Cancer research"},{"issue":"15","key":"pcbi.1007900.ref005","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1158\/0008-5472.CAN-17-2698","article-title":"Integrative modeling identifies key determinants of inhibitor sensitivity in breast cancer cell lines","volume":"78","author":"K Jastrzebski","year":"2018","journal-title":"Cancer research"},{"issue":"6","key":"pcbi.1007900.ref006","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cels.2018.10.013","article-title":"Efficient parameter estimation enables the prediction of drug response using a mechanistic pan-cancer pathway model","volume":"7","author":"F Fr\u00f6hlich","year":"2018","journal-title":"Cell Systems"},{"issue":"10","key":"pcbi.1007900.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1005662","article-title":"Learning causal networks with latent variables from multivariate information in genomic data","volume":"13","author":"L Verny","year":"2017","journal-title":"PLOS Computational Biology"},{"issue":"1","key":"pcbi.1007900.ref008","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2013.29","article-title":"Network quantification of EGFR signaling unveils potential for targeted combination therapy","volume":"9","author":"B Klinger","year":"2013","journal-title":"Molecular systems biology"},{"issue":"1","key":"pcbi.1007900.ref009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41236-017-0007-6","article-title":"A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer","volume":"1","author":"JGT Za\u00f1udo","year":"2017","journal-title":"Cancer convergence"},{"issue":"3","key":"pcbi.1007900.ref010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"F Iorio","year":"2016","journal-title":"Cell"},{"issue":"14","key":"pcbi.1007900.ref011","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/bioinformatics\/btx123","article-title":"MaBoSS 2.0: an environment for stochastic Boolean modeling","volume":"33","author":"G Stoll","year":"2017","journal-title":"Bioinformatics"},{"issue":"19","key":"pcbi.1007900.ref012","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1158\/0008-5472.CAN-15-0602","article-title":"A modeling approach to explain mutually exclusive and co-occurring genetic alterations in bladder tumorigenesis","volume":"75","author":"E Remy","year":"2015","journal-title":"Cancer research"},{"issue":"1","key":"pcbi.1007900.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep36812","article-title":"Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy","volume":"6","author":"TA Knijnenburg","year":"2016","journal-title":"Scientific reports"},{"issue":"2","key":"pcbi.1007900.ref014","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188664","article-title":"Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies","volume":"16","author":"F Eduati","year":"2020","journal-title":"Molecular systems biology"},{"issue":"11","key":"pcbi.1007900.ref015","doi-asserted-by":"crossref","first-page":"e1004571","DOI":"10.1371\/journal.pcbi.1004571","article-title":"Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration","volume":"11","author":"DPA Cohen","year":"2015","journal-title":"PLoS Computational Biology"},{"issue":"23","key":"pcbi.1007900.ref016","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1073\/pnas.1610622114","article-title":"Logical modeling of lymphoid and myeloid cell specification and transdifferentiation","volume":"114","author":"S Collombet","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"pcbi.1007900.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004426","article-title":"Discovery of drug synergies in gastric cancer cells predicted by logical modeling","volume":"11","author":"\u00c5 Flobak","year":"2015","journal-title":"PLoS computational biology"},{"issue":"3","key":"pcbi.1007900.ref018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","article-title":"BRAFV600E: implications for carcinogenesis and molecular therapy","volume":"10","author":"ER Cantwell-Dorris","year":"2011","journal-title":"Molecular cancer therapeutics"},{"issue":"26","key":"pcbi.1007900.ref019","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"PB Chapman","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"15_suppl","key":"pcbi.1007900.ref020","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1200\/jco.2010.28.15_suppl.3534","article-title":"PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors","volume":"28","author":"S Kopetz","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"7387","key":"pcbi.1007900.ref021","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF (V600E) inhibition through feedback activation of EGFR","volume":"483","author":"A Prahallad","year":"2012","journal-title":"Nature"},{"issue":"7377","key":"pcbi.1007900.ref022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature10662","article-title":"RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E)","volume":"480","author":"PI Poulikakos","year":"2011","journal-title":"Nature"},{"issue":"7494","key":"pcbi.1007900.ref023","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma","volume":"508","author":"C Sun","year":"2014","journal-title":"Nature"},{"issue":"3","key":"pcbi.1007900.ref024","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/2159-8290.CD-18-1321","article-title":"Targeting alterations in the RAF\u2013MEK pathway","volume":"9","author":"R Yaeger","year":"2019","journal-title":"Cancer discovery"},{"issue":"1","key":"pcbi.1007900.ref025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers12010028","article-title":"Connecting cancer pathways to tumor engines: a stratification tool for colorectal cancer combining human in vitro tissue models with boolean in silico models","volume":"12","author":"F Baur","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"pcbi.1007900.ref026","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12918-016-0341-9","article-title":"Attractor landscape analysis of colorectal tumorigenesis and its reversion","volume":"10","author":"SH Cho","year":"2016","journal-title":"BMC systems biology"},{"issue":"8","key":"pcbi.1007900.ref027","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMoa1502309","article-title":"Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations","volume":"373","author":"DM Hyman","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1007900.ref028","doi-asserted-by":"crossref","first-page":"1758835919856494","DOI":"10.1177\/1758835919856494","article-title":"Molecular targeted therapy of BRAF-mutant colorectal cancer","volume":"11","author":"M Ducreux","year":"2019","journal-title":"Therapeutic advances in medical oncology"},{"issue":"1","key":"pcbi.1007900.ref029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2012.10.012","article-title":"Boolean modeling of biological regulatory networks: a methodology tutorial","volume":"62","author":"A Saadatpour","year":"2013","journal-title":"Methods"},{"key":"pcbi.1007900.ref030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fgene.2016.00094","article-title":"Logical modeling and dynamical analysis of cellular networks","volume":"7","author":"W Abou-Jaoud\u00e9","year":"2016","journal-title":"Frontiers in genetics"},{"issue":"1","key":"pcbi.1007900.ref031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1752-0509-6-116","article-title":"Continuous time Boolean modeling for biological signaling: application of Gillespie algorithm","volume":"6","author":"G Stoll","year":"2012","journal-title":"BMC systems biology"},{"key":"pcbi.1007900.ref032","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fbioe.2019.00048","article-title":"Bio-ModelChecker: Using Bounded Constraint Satisfaction to Seamlessly Integrate Observed Behavior With Prior Knowledge of Biological Networks","volume":"7","author":"H Sedghamiz","year":"2019","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"pcbi.1007900.ref033","unstructured":"Hernandez C. Dynamical modelling of T cell inhibitory mechanisms in the immune response to cancer. Paris Sciences et Lettres; 2019. Available from: https:\/\/www.theses.fr\/s175716."},{"issue":"D1","key":"pcbi.1007900.ref034","doi-asserted-by":"crossref","first-page":"D923","DOI":"10.1093\/nar\/gky872","article-title":"Cell Model Passports\u2014a hub for clinical, genetic and functional datasets of preclinical cancer models","volume":"47","author":"D van der Meer","year":"2019","journal-title":"Nucleic acids research"},{"key":"pcbi.1007900.ref035","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fphys.2018.01965","article-title":"Personalization of logical models with multi-omics data allows clinical stratification of patients","volume":"9","author":"J B\u00e9al","year":"2019","journal-title":"Frontiers in physiology"},{"key":"pcbi.1007900.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"D Chakravarty","year":"2017","journal-title":"JCO precision oncology"},{"issue":"18","key":"pcbi.1007900.ref037","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"JR Conway","year":"2017","journal-title":"Bioinformatics"},{"issue":"408","key":"pcbi.1007900.ref038","doi-asserted-by":"crossref","first-page":"ra130","DOI":"10.1126\/scisignal.aab0990","article-title":"Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients","volume":"8","author":"D Fey","year":"2015","journal-title":"Sci Signal"},{"issue":"1","key":"pcbi.1007900.ref039","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12859-016-1235-y","article-title":"BTR: training asynchronous Boolean models using single-cell expression data","volume":"17","author":"CY Lim","year":"2016","journal-title":"BMC bioinformatics"},{"issue":"D1","key":"pcbi.1007900.ref040","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2012","journal-title":"Nucleic acids research"},{"issue":"7","key":"pcbi.1007900.ref041","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2217\/pgs.16.15","article-title":"Multilevel models improve precision and speed of IC50 estimates","volume":"17","author":"DJ Vis","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"7753","key":"pcbi.1007900.ref042","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens","volume":"568","author":"FM Behan","year":"2019","journal-title":"Nature"},{"issue":"12","key":"pcbi.1007900.ref043","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR\u2013Cas9 essentiality screens in cancer cells","volume":"49","author":"RM Meyers","year":"2017","journal-title":"Nature genetics"},{"issue":"1","key":"pcbi.1007900.ref044","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12859-016-1015-8","article-title":"BAGEL: a computational framework for identifying essential genes from pooled library screens","volume":"17","author":"T Hart","year":"2016","journal-title":"BMC bioinformatics"},{"issue":"1","key":"pcbi.1007900.ref045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13805-y","article-title":"Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data sets","volume":"10","author":"JM Dempster","year":"2019","journal-title":"Nature Communications"},{"issue":"1","key":"pcbi.1007900.ref046","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"L Breiman","year":"2001","journal-title":"Machine learning"},{"key":"pcbi.1007900.ref047","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1214\/07-EJS039","article-title":"Variable importance in binary regression trees and forests","volume":"1","author":"H Ishwaran","year":"2007","journal-title":"Electronic Journal of Statistics"},{"key":"pcbi.1007900.ref048","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/GICTT.S125940","article-title":"Emerging treatment options for BRAF-mutant colorectal cancer","volume":"8","author":"C Ursem","year":"2018","journal-title":"Gastrointestinal cancer: targets and therapy"},{"key":"pcbi.1007900.ref049","article-title":"Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents","author":"A Rossi","year":"2019","journal-title":"European journal of pharmacology"},{"issue":"11","key":"pcbi.1007900.ref050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"C Wellbrock","year":"2004","journal-title":"Nature reviews Molecular cell biology"},{"issue":"D1","key":"pcbi.1007900.ref051","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"U Consortium","year":"2019","journal-title":"Nucleic acids research"},{"issue":"23","key":"pcbi.1007900.ref052","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","volume":"73","author":"D Lake","year":"2016","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"4","key":"pcbi.1007900.ref053","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.109.055848","article-title":"Intermolecular interactions of Sprouty proteins and their implications in development and disease","volume":"76","author":"F Edwin","year":"2009","journal-title":"Molecular pharmacology"},{"issue":"38","key":"pcbi.1007900.ref054","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/bi049753e","article-title":"Identification of major ERK-related phosphorylation sites in Gab1","volume":"43","author":"S Lehr","year":"2004","journal-title":"Biochemistry"},{"issue":"D1","key":"pcbi.1007900.ref055","doi-asserted-by":"crossref","first-page":"D548","DOI":"10.1093\/nar\/gkv1048","article-title":"SIGNOR: a database of causal relationships between biological entities","volume":"44","author":"L Perfetto","year":"2016","journal-title":"Nucleic acids research"},{"key":"pcbi.1007900.ref056","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fphys.2018.00646","article-title":"Logical modeling and analysis of cellular regulatory networks with ginsim 3.0","volume":"9","author":"A Naldi","year":"2018","journal-title":"Frontiers in physiology"},{"issue":"1","key":"pcbi.1007900.ref057","first-page":"1","article-title":"ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma","volume":"9","author":"S Han","year":"2018","journal-title":"Nature communications"},{"issue":"3","key":"pcbi.1007900.ref058","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.18632\/oncotarget.13790","article-title":"FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway","volume":"8","author":"K Li","year":"2017","journal-title":"Oncotarget"},{"issue":"21","key":"pcbi.1007900.ref059","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1158\/0008-5472.CAN-10-0902","article-title":"Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells","volume":"70","author":"YV Gopal","year":"2010","journal-title":"Cancer research"},{"issue":"2","key":"pcbi.1007900.ref060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/bgs330","article-title":"The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance","volume":"34","author":"D Wroblewski","year":"2013","journal-title":"Carcinogenesis"},{"issue":"12","key":"pcbi.1007900.ref061","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.06.07","article-title":"Resistant mechanisms to BRAF inhibitors in melanoma","volume":"4","author":"JL Manzano","year":"2016","journal-title":"Annals of translational medicine"},{"issue":"7326","key":"pcbi.1007900.ref062","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"CM Johannessen","year":"2010","journal-title":"Nature"},{"issue":"3","key":"pcbi.1007900.ref063","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","article-title":"EGFR-mediated reactivation of MAPK signaling contributes to insensitivity of BRAF-mutant colorectal cancers to RAF inhibition with vemurafenib","volume":"2","author":"RB Corcoran","year":"2012","journal-title":"Cancer discovery"},{"issue":"12","key":"pcbi.1007900.ref064","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1158\/0008-5472.CAN-07-6787","article-title":"Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma","volume":"68","author":"C Montagut","year":"2008","journal-title":"Cancer research"},{"issue":"7","key":"pcbi.1007900.ref065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1158\/0008-5472.CAN-14-2785","article-title":"PDK1 and SGK3 contribute to the growth of BRAF-mutant melanomas and are potential therapeutic targets","volume":"75","author":"M Scortegagna","year":"2015","journal-title":"Cancer research"},{"issue":"17","key":"pcbi.1007900.ref066","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1158\/0008-5472.CAN-13-3338","article-title":"Using high-throughput transcriptomic data for prognosis: a critical overview and perspectives","volume":"74","author":"E Domany","year":"2014","journal-title":"Cancer research"},{"issue":"10","key":"pcbi.1007900.ref067","doi-asserted-by":"crossref","first-page":"e1006538","DOI":"10.1371\/journal.pcbi.1006538","article-title":"Computational discovery of dynamic cell line specific Boolean networks from multiplex time-course data","volume":"14","author":"M Razzaq","year":"2018","journal-title":"PLoS computational biology"},{"issue":"5","key":"pcbi.1007900.ref068","first-page":"820","article-title":"Computational models for predicting drug responses in cancer research","volume":"18","author":"F Azuaje","year":"2017","journal-title":"Briefings in bioinformatics"},{"issue":"17","key":"pcbi.1007900.ref069","doi-asserted-by":"crossref","first-page":"i413","DOI":"10.1093\/bioinformatics\/btw449","article-title":"TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types","volume":"32","author":"N Aben","year":"2016","journal-title":"Bioinformatics"},{"issue":"7287","key":"pcbi.1007900.ref070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"PI Poulikakos","year":"2010","journal-title":"Nature"},{"key":"pcbi.1007900.ref071","article-title":"Toward explainable anticancer compound sensitivity prediction via multimodal attention-based convolutional encoders","author":"M Manica","year":"2019","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"pcbi.1007900.ref072","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199042","article-title":"Personalized signaling models for personalized treatments","volume":"16","author":"J Saez-Rodriguez","year":"2020","journal-title":"Molecular Systems Biology"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007900","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T22:43:33Z","timestamp":1612910613000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007900"}},"subtitle":[],"editor":[{"given":"Joerg","family":"Stelling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007900","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.27.119016","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}